Did GlaxoSmithKline’s blockbuster diabetes drug Avandia cause fatal heart attacks? The first federal trial of an Avandia lawsuit began this morning in Philidelphia. As many as 50,000 more lurk in the wings.
Continue reading Glaxo Faces First of Many Possible Avandia Trials
Glaxo Faces First of Many Possible Avandia Trials originally appeared on DailyFinance on Mon, 24 Jan 2011 12:00:00.
Filed Under: Company News, Columns, Investing, GlaxoSmithKline, Stocks in the News